RxDoctor Payments Data

Nima Golchin, MD

Vascular & Interventional Radiology · Ames, IANPI 1063859981

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $5,471 of the $8,487 with a category attached, or 64.5%. 14 manufacturers reported payments, led by Medtronic at 30.4% of the total. Reporting peaked in 2019 at $3,554 and has fallen 87.0% since, to $462 in 2025.

$8,487in general payments, 2019–2025

Across 97 payments — averaging $87.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Inari Medical, Inc.$2K
  • Bard Peripheral Vascular, Inc.$914
  • Terumo Medical Corporation$741
  • Boston Scientific$706
  • Penumbra, Inc.$387
  • plus $728 from 8 others

What the payments were for

  • Travel & lodging$5,47164%
  • Food & beverage$2,92834%
  • Education$881%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,487 in reported general payments places this provider in the 80th percentile of 34 vascular & interventional radiology providers in Iowa.

See all vascular & interventional radiology providers in Iowa

Medicare billing

Part B allowed, 2024
$310,311
Medicare patients
2,478
Services billed
4,631

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate26$135
Ondansetron Hcl14$85
Cilostazol13$78
Oxycodone Hcl13$61
Ciprofloxacin Hcl12$42

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Ames

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →